8 results
Oral anticoagulant dosing and bridging for VTE

- Dr. Joseph Shatzel @Clotmaster 

#VTE #DOAC #Bridging #Dosing #Oral
Oral anticoagulant ... #DOAC #Bridging ... #Dosing #Oral #Anticoagulant ... #Anticoagulation ... #Dabigatran #Apixaban
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
and Novel Oral Anticoagulants ... subcutaneous) and oral anticoagulants ... or a new oral anticoagulant ... traditional oral anticoagulant ... #UFH #DOAC #Dabigatran
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
direct-acting oral anticoagulants ... direct-acting oral anticoagulant ... ; LMWH = low molecular ... #DOAC #VTE #Malignancy ... #Management #Hematology
â–º
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
Anticoagulants Common ... Kcentra) - Heparin/LMWH ... Protamine sulfate - Dabigatran ... PCC (Kcentra) #anticoagulation ... #hematology #reversal
Anticoagulant Bridging

 • Switching from LMWH
 • Switching from UFH
 • Switching from DOAC to Warfarin
Anticoagulant Bridging ... Switching from LMWH ... Kfischer_10 #Anticoagulant ... #Bridging #anticoagulation ... pharmacology #management #hematology
DOAC: Cheat Sheet - Atrial Fibrillation, VTE Prophylaxis, VTE and Renal Dosing

Renal Dosing:
Apixaban (25% renal clearance):
DOAC: Cheat Sheet ... - Atrial Fibrillation ... #CheatSheet #Dosing ... OralAnticoagulant #Anticoagulation ... #Hematology #Pharmacology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
consider withholding anticoagulant ... consider changing the anticoagulant ... decision to continue anticoagulant ... anticoagulant; ... #DOAC #VTE #Malignancy
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
utilize direct oral anticoagulants ... (DOACs) for bioprosthetic ... patients with chronic atrial ... #Management #Cardiology ... #INR #Target #DOAC